Novo Nordisk
NNNYSETrackedESG Rated: 1/2 ProvidersHealth CareDiversifiedMSCI: AAA
Public exchange feeds are not currently returning active trading data for Novo Nordisk (NN). This company may be delisted, bankrupt, acquired, or halted. To preserve data integrity, prices are never displayed as $0.00. Sourced ESG ratings and sustainability disclosures remain cataloged below.
- Coverage
- Rated universe Carries an MSCI or Sustainalytics observation.
- ESG profile reviewed
- Last editorial update to this profile.
- Quote
- Market data unavailableObservation time is shown beside the price.
- Methodology
- How we rateProvider ratings are shown separately, never blended.
Market overview
Market data unavailable
Massive Stock Widgets has not returned a current, verifiable snapshot for Novo Nordisk (nyse:NN). Check again later.
Company Profile & Business Model Overview
Novo Nordisk is a top-tier ESG performer in the pharma sector, renowned for its diabetes care and zero-impact environmental goals.
Sustainability Strengths & Catalysts (Pros)
- Top-tier ESG performer: holds an MSCI AAA rating and a Sustainalytics Low Risk score, with industry-leading ESRS-aligned sustainability reporting.
- Novo Nordisk demonstrates strong social performance through initiatives like its Access to Insulin Commitment, which guarantees the provision of low-cost human insulin to vulnerable populations in least-developed and low-income nations.
- The company maintains high standards in corporate ethics, diversity, and transparency, evidenced by the integration of sustainability reporting directly into its annual financial performance metrics and strong compliance frameworks aligned with European d
Material Risks & Governance Concerns (Cons)
- The company faces intense criticism, political pressure, and public scrutiny over the high list prices of its highly demanded blockbuster diabetes and obesity medications (specifically in the United States), creating a barrier to equitable healthcare acce
- The explosive global demand for its GLP-1 therapies has severely stressed its manufacturing supply chain, leading to global drug shortages and inadvertently fostering dangerous secondary markets for counterfeit products.
Related ESG Peer Equities
Companies in Health Care evaluated across carbon intensity, social metrics, and board governance.
ESG & Sustainability Rating Breakdown
Synthesized multi-provider rating across Environmental, Social, and Corporate Governance dimensions.
Audited Methodology
MSCI ESG industry rating benchmark.
Data integrity and methodology
MSCI and Sustainalytics ratings are shown separately with their own observation dates; they are not blended into one score, and providers can disagree. Market quotes are delayed or last-close values, and every snapshot states its source and observation time. Read the full rating methodology.
Financial & Valuation Fundamentals
Core balance sheet and equity valuation metrics sourced from corporate filings.
Audited Financials
Related ESG Financial Tools & Modeling
ESG Investment Growth Calculator
Project compound future portfolio values versus traditional index benchmarks.
Launch Tool →
Portfolio Carbon Footprint Calculator
Translate your investment capital into financed greenhouse gas emissions.
Launch Tool →
Green Mortgage Calculator
Calculate interest rate discounts on energy-efficient certified homes.
Launch Tool →
Featured Sustainable Investment Research & Guides
Top 12 Impact Investing Apps & Platforms (Reviewed)
Comprehensive review of the best ESG micro-investing and direct indexing apps.
Biblically Responsible Investing (BRI): Top Stocks & Funds
Faith-based screening criteria, ESG alignment, and values-based portfolio strategies.
Top Desalination & Clean Water Infrastructure Stocks
Invest in global clean water purification, reverse osmosis, and municipal utilities.
Best Certified B-Corp Banks & Sustainable Banking
How to align your everyday cash reserves with social and climate impact standards.
Frequently Asked Questions
Direct answers on sustainability scores, risk methodologies, and peer rankings.
What is Novo Nordisk (NN)'s ESG rating and sustainability score?
Novo Nordisk (NN) has an MSCI ESG rating of AAA. MSCI evaluates corporate resilience to long-term industry material environmental, social, and governance risks relative to sector peers.
Is Novo Nordisk considered an ESG leader or laggard in Health Care?
Novo Nordisk is classified as an ESG Leader by MSCI with a AAA rating, ranking in the top tier of companies in Health Care for sustainability governance and decarbonization practices.
What are the main ESG risks and controversies for Novo Nordisk?
Key material risks for Novo Nordisk include: The company faces intense criticism, political pressure, and public scrutiny over the high list prices of its highly demanded blockbuster diabetes and obesity medications (specifically in the United States), creating a barrier to equitable healthcare acce; The explosive global demand for its GLP-1 therapies has severely stressed its manufacturing supply chain, leading to global drug shortages and inadvertently fostering dangerous secondary markets for counterfeit products.. Investors should evaluate whether corporate mitigation plans adequately address these vulnerabilities.
How does The Impact Investor evaluate ESG stock profiles?
The Impact Investor presents audited third-party ratings from MSCI and Sustainalytics alongside delayed market data and financial fundamentals. We do not blend ratings into proprietary black-box scores, and ratings are never modified by advertising or affiliate relationships.